OpenAlex
PricingAboutJobs
Log inGet started
Work

The safety of gliptins : updated data in 2018

HTML

Year: 2018
Type: review
Source: Expert Opinion on Drug Safety
DOI: 10.1080/14740338.2018.1444027
Author: André Jacques Scheen
Institutions: University of Liège, Centre Hospitalier Universitaire de Liège
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: DPP-4 inhibitors, drug safety, type 2 diabetes, alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin, hypoglycemia, pancreatitis, pancreatic cancer, cardiovascular events, heart failure hospitalization, bone fractures, joint pain, renal dysfunction, liver disease, elderly patients, pharmacovigilance
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2793303845
FWCI: 2.387
Cites: 183
Cited by: 140
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security